Skip to main content
John Koo, MD, Dermatology, San Francisco, CA, UCSF Medical Center

JohnY.M.KooMD

Dermatology San Francisco, CA

Professor of Dermatology, UCSF

Dr. Koo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Koo's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Dermatology, 1985 - 1988
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1982 - 1985
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1981 - 1982
  • Harvard Medical School
    Harvard Medical SchoolClass of 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2026
  • American Board of Dermatology Dermatology
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Impact of Pediatric Atopic Dermatitis on Families: A Review  
    John Koo, Tina Bhutani, Pediatric Dermatology
  • Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the National Psoriasis Foundation  
    Ronald Prussick, Johann E Gudjonsson, Alice Gottlieb, John Koo, Jerry Bagel, Adam R Ford, Joseph A Markenson, Wilson Liao, Joseph F Merola, Jashin J Wu, JAMA

Lectures

  • Psychocutaneous Disease: Treating the Difficult Patient 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Press Mentions

  • Alopecia’s Impact on Mental Health
    Alopecia’s Impact on Mental HealthMay 15th, 2023
  • Brodalumab: 4-Year US Pharmacovigilance Report
    Brodalumab: 4-Year US Pharmacovigilance ReportMarch 14th, 2023
  • EPI Health and MC2 Therapeutics Announces U.S. Launch of Wynzora® Cream for Plaque Psoriasis (Calcipotriene and Betamethasone Dipropionate w/w 0.005%/0.064%)
    EPI Health and MC2 Therapeutics Announces U.S. Launch of Wynzora® Cream for Plaque Psoriasis (Calcipotriene and Betamethasone Dipropionate w/w 0.005%/0.064%)July 19th, 2021
  • Join now to see all

Hospital Affiliations